DDOG vs MRK: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Datadog, Inc. · Technology
$200.16
+45.0% upside to fair value
Grade C
High Quality
VS
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
DDOG has more upside to fair value
(+45.0%).
MRK trades at a lower forward P/E
(22.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
MRK |
| Current Price |
$200.16 |
$114.27 |
| Fair Value Estimate |
$290.23 |
$118.00 |
| Upside to Fair Value |
+45.0%
|
+3.3%
|
| Market Cap |
$71.2B |
$282.2B |
| Forward P/E |
521.2x
|
22.4x
|
| EV / EBITDA |
415.7x
|
13.5x
|
| Price / Sales |
19.4x
|
4.3x
|
| Price / FCF |
66.0x
|
20.2x
|
| Revenue Growth YoY |
+32.2%
|
+5.0%
|
| Gross Margin |
79.9%
|
81.9%
|
| Operating Margin |
-0.7%
|
27.5%
|
| Return on Equity |
3.8%
|
5.6%
|
| Dividend Yield |
0% |
2.91% |
| FCF Yield |
1.51%
|
4.95%
|
| Analyst Consensus |
Strong Buy
|
Overweight
|
Investment Thesis
Datadog, Inc. is a leading cloud-based monitoring and analytics platform specializing in observability and security solutions for enterprise IT infrastructure. The company demonstrates high business quality with durable competitive moats driven by product integration, developer-centric design, and scale. Despite strong revenue growth of 27.8% year-over-year in fiscal 2025 and earnings growth of 1…
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Accumulation Zones
| Metric |
DDOG |
MRK |
| Zone Low |
$217.67 |
$88.50 |
| Zone High |
$246.70 |
$100.30 |
| In Buy Zone? |
Yes
|
No
|